SRXH — SRx Health Solutions Income Statement
0.000.00%
Last trade - 00:00- $13.40m
- $16.55m
- $6.53m
Annual income statement for SRx Health Solutions, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 46 | 54.7 | 38.6 | 35 | 6.53 |
| Cost of Revenue | |||||
| Gross Profit | 15.4 | 15.3 | 11.8 | 13 | 1.53 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 62.8 | 93.4 | 59.8 | 34.7 | 14.5 |
| Operating Profit | -16.8 | -38.8 | -21.2 | 0.239 | -8.01 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 3.42 | -39.3 | -22.8 | -0.159 | -8.64 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 3.39 | -39.3 | -22.8 | -0.168 | -8.64 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 3.39 | -39.3 | -22.8 | -0.168 | -45 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2.98 | -39.3 | -22.8 | -0.168 | -45 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5.09 | -40.8 | -24.4 | -2.6 | -0.267 |